Humana stock closes down 2.37%; Medicare ratings upgrade reported after the bell

Cryptonomist2026/10/09 14:24

By: Cryptonomist

Humana stock presents a neutral daily chart, with Thursday’s close at $387.12 below the 20-session EMA but above the 50-session EMA. The hourly chart adds bearish pressure.

On Thursday, October 8, 2026, Humana opened at $396.03, traded between a low of $375.86 and a high of $399.19, and closed at $387.12, against a previous close of $396.51. Volume was 2,658,300 shares. Prices and technical indicators are from Twelve Data.

Humana stock closes down 2.37%; Medicare ratings upgrade reported after the bell image 0

HUM — daily chart with candlesticks, EMA20/EMA50 and volume.

Summary

Key takeaways
Humana stock: a neutral daily bias with conflicting momentum
Hourly weakness limits the bullish reading for Humana
Medicare ratings reports belong to the later news backdrop
Bullish and bearish conditions for Humana stock
FAQ

Key takeaways

Humana closed Thursday at $387.12, below the 20-session EMA ($390.48) but above the 50-session EMA ($385.1).
Daily RSI14 is 48.33, below the neutral 50; the daily MACD histogram is positive at 0.79, with the MACD line (1.2) above its signal (0.41).
The hourly chart is bearish: price sits below all three hourly EMAs, hourly RSI14 is 44.05, and the hourly MACD line (-2.25) is below its signal (-0.3).
Daily ATR14 increased to $14.69 from $14.02 in the preceding session.
A report published after Thursday’s close said Humana’s largest Medicare Advantage contract rose from 3.5 to 4 stars; another report on Friday said 95% of Medicare members are in 4-star-plus plans.

Humana stock: a neutral daily bias with conflicting momentum

The close sits below the 20-session EMA at $390.48 but above the 50-session EMA at $385.1. The 200-session EMA stands at $326.85. That positioning leaves near-term resistance overhead while preserving support at the intermediate average; it is not a fully bullish alignment.

However, daily momentum is mixed rather than uniformly bearish. RSI14 stands at 48.33, below the neutral 50 threshold. The MACD line is 1.2, above its signal at 0.41, with a positive histogram of 0.79. MACD therefore retains a positive signal despite the RSI’s weaker position.

The daily Bollinger mid-band at $389.53 also sits above the close, between the lower band at $368.18 and upper band at $410.88. This adds a volatility caution to a setup without clear directional agreement.

Hourly weakness limits the bullish reading for Humana

In contrast, the hourly chart is less supportive. The session close sits below all three hourly EMAs: the 200-hour at $389.89, the 50-hour at $392.11, and the 20-hour at $392.43. Price is below all three, even though the 20-hour EMA sits above the 50-hour and the 200-hour.

Hourly RSI14 is 44.05, below 50. The MACD line at -2.25 is below its signal at -0.3, while the histogram is -1.96. This negative hourly signal weakens the daily MACD’s positive reading and keeps the main thesis neutral rather than bullish.

Meanwhile, the 15-minute chart offers only execution context. The close sits above its 20-period EMA at $386.69 but below the 50-period EMA at $390.92 and 200-period EMA at $392.34. RSI14 is 49.2, below 50. Its MACD line at -1.68 is above the signal at -2.53, with a positive histogram of 0.86. That short-term signal does not override the hourly weakness.

Medicare ratings reports belong to the later news backdrop

A report published after Thursday’s close said Humana’s largest Medicare Advantage contract covered more than 2 million members. It reported an increase from 3.5 stars to 4, putting the contract above the bonus threshold.

On Friday, October 9, a report said that Humana had 95% of Medicare members in 4-star-plus plans. Another Friday report linked stock gains to a Medicare Star Ratings boost from Evercore. A report described Humana as the top beneficiary of the 2027 Medicare star ratings.

A report also noted a 15% premarket gain on Friday and a Medicare upgrade. That was the later premarket figure, not Thursday’s session return or an updated chart price. All these reports were published after Thursday’s session.

Bullish and bearish conditions for Humana stock

When trading resumes, the daily pivot sits at $387.39, with first resistance at $398.92 and first support at $375.59. These levels are calculated from the completed daily candle and apply to the next session.

A bullish case would require holding the 50-session EMA at $385.1 and clearing the daily pivot at $387.39. Above that, the Bollinger mid-band at $389.53 and 20-session EMA at $390.48 are successive hurdles. Acceptance above those levels, alongside an hourly MACD line above its signal, would support a stronger bullish reading. Daily first resistance at $398.92 would then be the next reference.

Conversely, a break below the 50-session EMA at $385.1 would undermine that case. The session low at $375.86 comes before daily first support at $375.59, followed by the lower Bollinger band at $368.18. For short-term timing when trading resumes, the 15-minute pivot is $386.63, with first resistance at $388.89 and first support at $385.07.

Overall, the $387.12 session close lies between daily support at the $385.1 EMA and resistance at the $390.48 EMA. ATR14 at $14.69 keeps volatility central to the assessment. The unresolved question is whether the later Medicare news will be matched by price acceptance above the chart’s overhead levels.

FAQ

What is the daily trend structure for Humana stock?

Humana’s daily chart is neutral. Thursday’s close at $387.12 sits below the 20-session EMA at $390.48 but above the 50-session EMA at $385.1. Daily RSI14 at 48.33 is below the neutral 50, though the MACD retains a positive signal with the line at 1.2 above its signal at 0.41 and a positive histogram of 0.79.

What do the Medicare star ratings reports say?

A report published after Thursday’s close said Humana’s largest Medicare Advantage contract, covering more than 2 million members, increased from 3.5 to 4 stars, placing it above the bonus threshold. Another report on Friday, October 9, said that 95% of Humana’s Medicare members are in 4-star-plus plans. These reports were published after the session.

What are the key levels to watch for Humana stock?

The daily pivot for the next session is $387.39, with first resistance at $398.92 and first support at $375.59. The 50-session EMA at $385.1 and the 20-session EMA at $390.48 are key reference points. The Bollinger mid-band sits at $389.53, with the lower band at $368.18 and upper band at $410.88. Daily ATR14 is $14.69.

{"@context":"","@type":"FAQPage","mainEntity":[{"@type":"Question","name":"What is the daily trend structure for Humana stock?","acceptedAnswer":{"@type":"Answer","text":"Humana's daily chart is neutral. Thursday's close at $387.12 sits below the 20-session EMA at $390.48 but above the 50-session EMA at $385.1. Daily RSI14 at 48.33 is below the neutral 50, though the MACD retains a positive signal with the line at 1.2 above its signal at 0.41 and a positive histogram of 0.79."}},{"@type":"Question","name":"What do the Medicare star ratings reports say?","acceptedAnswer":{"@type":"Answer","text":"A report published after Thursday's close said Humana's largest Medicare Advantage contract, covering more than 2 million members, increased from 3.5 to 4 stars, placing it above the bonus threshold. Another report on Friday, October 9, said that 95% of Humana's Medicare members are in 4-star-plus plans. These reports were published after the session."}},{"@type":"Question","name":"What are the key levels to watch for Humana stock?","acceptedAnswer":{"@type":"Answer","text":"The daily pivot for the next session is $387.39, with first resistance at $398.92 and first support at $375.59. The 50-session EMA at $385.1 and the 20-session EMA at $390.48 are key reference points. The Bollinger mid-band sits at $389.53, with the lower band at $368.18 and upper band at $410.88. Daily ATR14 is $14.69."}}]}

Article produced with the assistance of artificial intelligence and reviewed by the editorial team.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Delta Airlines lowers its annual profit forecast due to an expected increase in fuel costs to $6 billion. The CEO stated that ticket prices have risen by about 20% this year, with limited passenger resistance. Analysts warn that maintaining high ticket prices in 2027 is critical for improving profitability. The article includes comments from the earnings call and analyst remarks. Rajesh Kumar Singh/Shivansh Tiwary, Reuters Chicago, October 9 - Delta Airlines (DAL.N) said on Friday that, despite strong travel demand and rising ticket prices, soaring fuel costs have forced it to cut its 2026 profit expectations by nearly a quarter. So, the airline industry may need to further limit flight growth next year to protect profitability. This warning highlights the increasingly tough challenges faced by U.S. airlines. While strong demand and restricted seat growth have allowed airlines to significantly raise ticket prices and offset higher fuel costs, aggressively increasing flights to capture more demand may intensify competition, making it harder to maintain high fares and protect profits. Based in Atlanta, Delta now expects its annual fuel expenditure to increase by about $6 billion compared to last year—about $2 billion higher than its July forecast—due to the Iran war (link) causing global jet fuel prices to spike. Airlines worldwide are preparing for a prolonged fuel shock. Michael O’Leary, CEO of Ryanair Group RYA.I, said Thursday that high jet fuel prices could persist for another 12-18 months (link), adding more pressure on airlines to raise fares and control costs. https://www.reuters.com/graphics/AUTOMATED-20261008/A4A-JET-FUEL-DAILY-1Y/xmpjwjnmbvr/chart.png “In a high-cost environment, you can’t simply grow your way out,” Delta CEO Ed Bastian said on the earnings call. He noted that the industry has already taken steps to restrict capacity, but more measures will be needed next year to improve profitability. Bastian said Delta raised ticket prices about 20% this year, and passenger resistance has been limited. He is confident that even if fuel costs eventually drop, the high fares can still be maintained. Delta lowered its adjusted annual earnings per share forecast from the July prediction of $6.50-$7.50 to $5.10-$5.60. According to LSEG data, the midpoint of the new range is below analysts’ average expectation of $5.46. Third-quarter adjusted earnings per share were $1.72, four cents below analysts’ average forecast. In midday trading, shares of Delta dropped 1.7%, United Airlines UAL.O fell 1.4%, and both American Airlines AAL.O and Southwest Airlines LUV.N were down about 1%. Delta partly shields itself from rising fuel costs by owning a refinery outside Philadelphia (link), which is expected to generate over $700 million in profits this year. Even with this buffer, the airline expects its fourth-quarter fuel price to rise from $3.61 per gallon in Q3 to $4.25 per gallon. Delta forecasts adjusted fourth-quarter earnings per share to be between $1.15-$1.65, with the $1.40 midpoint roughly matching analysts’ average expectation of $1.39. Fare increases Government data shows that in the first eight months of 2026, U.S. airlines spent $42.9 billion on fuel, an increase of $13.2 billion compared to the same period last year despite slightly reduced consumption. According to the U.S. Bureau of Labor Statistics, strong demand and limited seat growth pushed average U.S. airline ticket prices up by about 25% year-on-year between April and August. https://www.reuters.com/graphics/USA-AIRLINES/FUEL/lbpgdnbzwvq/chart.png Analysts at Melius Research said that despite surging fuel costs, Delta’s ability to raise fares helps keep second-half profits roughly stable. Still, they warn that the company’s profit margin has struggled to improve over the years. “It is critical for margin improvement to maintain or raise fares in 2027,” they wrote in their research report. With industry capacity growth expected to accelerate in Q4, this challenge will likely become even tougher. Deutsche Bank analysts expect the proportion of fuel costs recouped through revenue measures to fall in Q4 and predict full recovery won’t happen until early 2027. Bastian noted that low industry returns are another reason for limiting capacity growth. He said Delta will be cautious with its 2027 capacity plan until the fuel price outlook becomes clearer. He added that international routes may account for a larger share of Delta’s capacity expansion compared to domestic routes. Currently, Delta says its premium cabins and corporate travel business remain strong, and its economy cabin business is gradually improving. With Q4 ticket bookings already exceeding 60%, Delta expects revenue to increase about 20% year-on-year, despite limited capacity growth. Executives said early booking trends for Q1 2027 are also encouraging. (For the convenience of non-native English speakers, Reuters automatically translates its reports into several

路透社•2026/10/09 17:36

AI and Quantum: Trump's $6 Billion Plan Could Also Impact Bitcoin

Cointribune•2026/10/09 16:24